Clinical Trial Update: Treg Cells for AGVHD in Non-myeloablative UCB Transplant [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating regulatory T cells to prevent acute graft-versus-host disease in non-myeloablative umbilical cord blood transplantation h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematologic Malignancies

Drugs mentioned

• Regulatory T Cells (regulatory T cells)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Hematologic Malignancies | Phase 2 | Status: WITHDRAWN